Founder Stories: Kenneth Mills - Co-Founder and CEO of Regenxbio, a pioneer in gene therapies
Channel: Axial
Date: 2020-04-23

Regenxbio is a fascinating business that is powering gene therapies that are curing disease. The company is an interesting case study on how to set a standard in life sciences, in the case of Regenxbio making adeno-associated virus (AAV) the standard vector for most gene therapies. The founders used this to build a unique business. Founded in 2009 by James Brown (COO) and Kenneth Mills (CEO), Regenxbio formed from a collaboration between the biotechnology consultancy firm FoxKiser, Penn, and the Wilson Lab. James and Kenneth were both trained as chemists and worked at a diagnostics company called IGEN in the late 1990s and early 2000s then both at Meso Scale Diagnostics, a joint venture between IGEN and Meso Scale Technologies. Before forming Regenxbio, they were both working at FoxKiser.

Case study on Regenxbio - https://axial.substack.com/p/axial-regenxbio

Source: Alliance for Regenerative Medicine

#biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews 

Axial Newsletter: https://axial.substack.com/
Build with Axial: https://axial22.axialvc.com/